Inside Genomics:
Q&A: Brian Haas
of the Broad Institute
Narges Bani Asadi , Ph.D.
O
ne of the elements lacking in the personalized medicine discussion today is the perspective of leading clinicians, informaticians and academics working in the
field. To remedy the gap, I've asked a series of industry leaders to offer up their views.
I recently spoke with Brian Haas at the Broad Institute, who gave a talk
on more efficiently assembling RNA-Seq data via a massively parallel
computing architecture.
With degrees in both molecular biology and computer science, Brian
sits squarely at the intersection between biology and high performance computing. He is the lead developer of the Trinity RNA-Seq
de novo assembly software and has over a decade of experience in
genomics and bioinformatics. He worked at The Institute of Genomic
Research/J. Craig Venter Institute for eight years before joining the
Broad Institute, where he has co-authored numerous scientific publications in leading journals and developed several popular Open
Source bioinformatics tools that are widely used by the genomics
community for genome and transcriptome research.
NARGES BANI ASADI, Ph.D.
is the founder and CEO of Bina Technologies,
a company that analyzes and interprets whole
human "omes" quickly and at scale.
16
Clinical OMICs June 26, 2014
www.clinicalomics.com
http://www.clinicalomics.com
Table of Contents for the Digital Edition of Clinical OMICs - Issue 6